Skip Main Navigation
Page Content
Unavailable

World Congress On Cancer Science And Therapy (PGR) S

Event Information

Share this event

Date and Time

Location

Location

Venue will be informed to the Registered Participants

San Antonio, TX 78216

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

World Congress On Cancer Science And Therapy

About Conference
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders, or rub elbows with pioneers across the globe. PULSUS proudly presents the “World Congress on Cancer Science and Therapy ” slated on November 14-15, 2018 at San Antonio, USA.

PULSUS cordially welcome researchers, academicians, students and business professionals in the field of cancer science and therapy from different part of the world to participate in the upcoming Cancer Science 2018. The meeting for this year will revolve around the theme “The Leading Edge on Cancer Science and Therapy” thus relaying the most cutting edge findings in the field of Cancer Research.

Pulsus Group is an international level publisher in scientific, technical, and medical journals established within the year 1984 with offices in Ontario and Canada, India has reaped Andrew John publishing and open access journals.com to expand it Open Access publishing through its 50+ journals in association with 20+ International medical and scientific societies.

Cancer science 2018 will replenish new ideas and techniques in cancer therapy and evolution in cancer Science based on the following topics: Cancer Cell Biology, Cancer Biomarker, Cancer Immunotherapy, Cancer Immunology, Cancer Cell Biopsy, Cancer Stem cell etc. It will focus on the current and astonishing innovations in every area of cancer science research. Cancer Science 2018 is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers about the on new developments that impact and advance future of cancer science. It serves as a global platform regarding the current developments, recent advances, new approaches in the field of cancer science and therapy. This event is an effort to understand the underlying new techniques which are amended to increase effectiveness, accuracy, sustainability, and quality of life.

Why to attend?

The entire world is focused on learning about cancer science and Therapy , so this is the best opportunity to reach largest meeting of participants from the Cancer community. Distribute information, conduct presentations and meet with current and potential scientists. Make a splash with new researches and its developments in this 2-day event at Cancer Science 2018 conference. World-renowned speakers, recent techniques, developments and newest updates in cancer treatment are major parts of this conference

Target Audience:

• Academicians

• Medical Colleges

• Research faculty

• Students

• Oncologists

• Pathologists

• Cancer & Oncology Societies Professionals

• Diagnostic laboratory professionals

• Presidents & Vice Presidents

• Directors/Managers/CEO’s

• Bio-Medical Company professionals

• Industry Professionals

• Corporate Cancer Research Professional

• Pharmacists Business Entrepreneurs

• Medical Devices Companies

• Biotechnology Companies

• Marketing, Advertising and Promotion Agency Executives .

About San Antonio:

San Antonio, formally known as the City of San Antonio is the second most populated city in the state of Texas and the seventh most populated city in the United States of America. San Antonio was named after Saint Anthony de Padua. The UNESCO world heritage sites in San Antonio are The Alamo and San Antonio Missions National Historic Park. The economy is based chiefly on healthcare, military, civil service, tourism, financial services & oil & gas. The city has well flourished heritage and traditions. San Fernando Cathedral, San Antonio Missions National Historical Park, Aztec Theatre, San Antonio Museum of Art, Natural Bridge Caverns, Day Trip to Bandera & New Braunfels and Sea world are outstanding places to be seen in San Antonio. San Antonio International Airport has facility from major of the International terminals. The University of Texas Health Science Center at San Antonio is the largest health sciences university and the primary training site for health professionals in South Texas. VIA Metropolitan Transit in San Antonio provide transportation all over the city.

Scientific Sessions
Session 01: Cancer Cell Biology

The cancer cell biology contains in-depth information about the structure and function of normal cell and tumour cell. The cancer form series of molecular events that alter the properties of normal cells. The altered cells would divide and grow and the no longer required special signals to induce cell growth and division. As these cells grow they develop new characteristics including changes in cell structure, such changes make cancer cell to spread and invade other tissues. Thus it leads to detail understanding of process of tumorigenesis at the molecular level and created novel opportunities to specifically target the modified genes.

Ø Circadian Clocks & UPR

Ø Advancements And Challenges In EMT

Ø Role Of PERK

Ø Imaging Organoids

Ø High Content Analysis

Session 02: Tumour Immunology

Tumour immunology is a branch of biology that deal with role of immune system in the progression and development of cancer. The tumour cells has a capacity to escape immune response by modulating the key target molecules. Tumour are infiltrated by a broad range of immune cell types which have distinct functions in Tumour Micro Environment (TME). The immune system will play a major role for tumorigenesis and metastasis. The immune response, including the recognition of cancer-specific antigens leads to development of targeted therapy and tumor marker-based diagnostic tests. Thus it lead to better understanding in manipulating immune system to fight against cancer.

Ø The Achilles Heel Of Cancer

Ø Mechanistic Insights

Ø Complement System In Cancer

Ø Role Of CD8+ T cell In Solid TME

Session 03: Tumour Immunotherapy

Tumour immunotherapy is a therapy to treat cancer that involves or uses the components of immune system. In last few decades the immunotherapy has become important part in treating some types of cancer. Immunotherapy includes treatments which work in different ways. some therapies boost the body immune system, but other therapies will train the immune system to attack the cancer cells specifically. The success of these therapies illustrates the importance of careful decoding of basic immunology for successful clinical translation in treating cancer. It provides new insights into the mechanisms that underlie cancer immune evasion might lead to pathways for identifying novel and efficacious treatments.

Ø Immune -Vascular Cross-talk

Ø T-cell Based Immunotherapy

Ø Solid Tumour Immunotherapy

Ø Role Of CircRNA

Ø Immune Checkpoints Inhibitors

Session 04: Cancer Metastasis

Metastasis is the complex series of step in which cancer cell leave the original tumour site and migrate to distant location in the body . Metastasis is the inefficient process. Most of the cancer cell will die during the process. It helps to determine staging and treatment. Angiogenesis is the critical step for cancer metastasis. The body resist metastasis by variety of mechanism through the action of class of proteins called "Metastasis Suppressor". Most tumour and neoplasm will metastasize. The degree of ability to metastasize varies between different types of cancers. For example, bladder cancer that metastasizes to the liver is not liver cancer. It is called metastatic bladder cancer.

Ø Tumour Adipose Tissue Cross Talk

Ø SOCE In Cancer Metastasis

Ø Role Of DDR

Ø IL-1 & IL-2 Regulatory Pathway

Session 05: Cancer Metabolomics

The Cancer Metabolomics attempts to study all metabolism within a tumour cell which helps to analyse the cancer metabolism which includes a broad picture of altered pathway and their interaction with each other. The metabolic profile are mainly affected by environmental changes and therefore by directly measuring metabolites may provide epigenetically Related information of cancer. The metabolomics research is used to obtain the mechanistic insights into cancer and also emerging in areas such as tumour staging and assessment of treatment efficacy.

Ø Pharmacometabolomics

Ø NMR Based Metabolomics

Ø Cancer Biomarker Discovery

Ø Desmoid Tumour

Session 06: Cancer Diagnosis &Therapies

There are several methods for diagnosing cancer. With advanced technologies there is a rise number of diagnostic tools that will help to detect cancer. some of the cancers are hard to classify in such case second opinion is needed before being diagnosis. The treatment of cancer depend on the type of cancer. Cancer therapy describes treatment of cancer in a patient often with surgery or radiotherapy. Advanced therapies are also available for some type of cancer oncology immune-oncology treatments can be delivered using a variety of techniques and classes of agent such as Monoclonal antibodies, Small molecules etc..

Ø Dendritic Polymer Based Nano Material

Ø Multimodal Cancer Therapy

Ø Role Of Aptamers

Ø Nanotheranostics

Ø Radiotheranostics

Session 07: Cancer Stem Cell

Cancer stem cell play a important role in cancer initiation and progression. CSC characterized by self-renewal and capacity to differentiate. The particular population of cancer stem cell are Mesenchymal stem cell they have potential pro and anti-tumorigenic properties and it is associated with tumorigenesis. The interaction between MSC's and cancer cell is the fundamental for metastasis and progression. The discovery of tumor stem cells in a range of cancers has created opportunities for researchers to identify rare cells in both solid tumors and hematologic cancers, as well as to investigate the role of these cells at different stages of disease.

Ø Role Of CD44 & CSC

Ø ALDH Activity Assay

Ø Therapeutic Potential Of MSC

Ø CSC In Tissue Generation

Ø Clinical Oncology

Session 08: Targeted Cell Therapy

Targeted Cell Therapy has long been as a cornerstone of medical therapies for malignancies. It targets the specific pathway in growth and development of tumour cell. Targeted Cell Therapy is favourable for rapidly dividing cells and malignant cells. This type of treatment is toxic for all type of cells. The targets are basically small molecules that play a major role in cancer formation. Many of the targets are tyrosine kinase that affects molecular signalling.

Ø TEM8/ANTXR1-Specific CAR T Cells

Ø Novel Carbonic Anhydrase IX

Ø Fluorogenic Reaction-Based Prodrug Conjugates

Ø Transcriptional Repression

Session 09: Breakthroughs In Cancer Therapy

A new method to kill tumour cells called Caspase Independent Cell Death (CICD) that decrease the side effects and boost the host immune system to get rid of all tumour cells . A new emerging approach is called Adoptive Cell Transfer (ACT) that uses the own immune cells to treat cancer. There are several types of ACT one of the type has advanced in clinical development called as CAR T-cells. They are known as "living cells". They are the synthetic molecules. The CAR-T cells target CD19 that is a cell surface molecules for most leukaemia and lymphomas.

Ø Caspase Independent Cell Death

Ø CAR-T Therapy (chimeric antigen receptor)

Session 10: Artificial Intelligence In Cancer Therapy

Artificial intelligence improves the accuracy of cancer diagnosis. A machine learning algorithm has been developed using deep learning approach which interprets complex pattern observed in real life data. It is used to make pathological diagnosis of cancer more accurate and predictive. It provide new insights into biophysics of cancer.

Ø Deep learning Algorithms

Ø Immunity - Machine Interface

Ø Cryptography Therapy

Ø Generative Adversarial Network

Session 11: Cancer Biopsy

Cancer Biopsy involves taking of small sample of body tissue to investigate abnormalities and it is also used to assess the severity and grade. There are different types of biopsy procedure they are incisional biopsy, excisional biopsy and needle biopsy. when fine needle is used it is called as fine needle aspiration biopsy. In case of using wide needle it is called as core needle biopsy. Scientist have been exploring a new approach called as liquid biopsy it analyse the bits of tumor material molecule and a whole cell that are found in body fluids such as blood and urine.

Ø Liquid Biopsy

Ø Optical biopsy

Ø MRI Ultrasound Fusion Biopsy

Ø Streostatic Breast Biopsy

Session 12: Cancer Biomarkers

Cancer Biomarker is a substance that indicate the presence of cancer in the body. It may be a substance that are secreted by the tumour or the specific response of the body in presence of cancer. The advancement in biomarker leads to discovery of new drug targets. The biomarker are found in variety of fluids , tissues and cell lines. The Biomarkers can be DNA, RNA, protein or metabolite. It helps to understand the drug metabolism ,drug action, safety and efficacy. It also provide information about the disease type and it predict response to therapies.

Ø Serum Thymidine Kinase 1

Ø Platelet Protein

Ø CTC-derived AR-V7

Ø Assessment Of CTC

Session 13: Cancer Therapeutics

​A combined discipline of medical oncology, which may be defined as the non-surgical, non-radiotherapeutic management of patients with solid tumours and clinical pharmacology, based on classic cytotoxic chemotherapy and the new signal transduction inhibitors. Cancer drug development is leading the way in exploiting molecular biological and genetic information to develop 'personalized' medicine. The new paradigm is to develop agents that target the precise molecular pathology driving the progression of individual cancers.

Ø Tumour Associated Macrophages

Ø Nanoparticle Based Delivery Systems

Ø Molecular Targeting

Session 14: Novel Approaches In Cancer Drug Discovery

Recent advances in platform technologies and the increasing availability of biological 'big data' are providing an opportunity to systematically identify the key genes and pathways involved in tumorigenesis. The discoveries made using these new technologies may lead to novel therapeutic interventions. These approaches include the analysis of genomic sequencing data, pathway data, multi-platform data, identifying genetic interactions such as synthetic lethality and using cell line data. They revealed how big data is being used to identify novel drug targets.

Ø Tumour Agnostic Cancer Drugs

Ø Non Coding RNAs

Ø Cell Surface Proteomics

Ø oncogenic transcription factors by polyphenols

Session 15: Cancer Treatment

The treatment for cancer is vacillating and dependent on a number of factors including the type, location and amount of disease, and the health status of the patient. Most treatments are designed to kill or remove the cancer cells and lead to their eventual death by depriving them from signals needed for survival. Other treatments work by stimulating the body's own immune system against the cancer cells. There are three general types of cancer treatments. They are radiation therapy, surgery and systemic therapy

Ø Next Generation Targeted Therapies

Ø DNA cages

Ø Molecular Cancer Diagnostics

Ø Multifunctional Radiology

Ø Insilico trials

Session 16: Technology Advances In Cancer Treatments

A new advanced technology in cancer treatment is called ChemoID. In ChemoID, an oncologist has a chance of using the most effective chemotherapy drugs for a patient particular cancer. Through which it can determine which medicines kill the cells most effectively. There are many other advancements such as linear accelerator, Three dimensional conformal radiation therapy, IMRT,IMGT etc.. Advancements in technology have lessened much of that danger and made treatment into a safer, more effective form of treatment.

Ø Personalized Medicine And Cancer

Ø Nanoparticles- A developing solution

Ø High Dosage Rate Brachytherapy

Ø Three Dimensional Conformational Radiation Therapy

Ø IGRT

Ø IMRT

Session 17: Cancer Epidemiology

Cancer Epidemiology is a branch of science that deals with the cancer distribution, incidence and prevention of disease and other factors related to health. The ultimate goal is to identify the major risk factors they may lead to effective preventive measures. It represents the study of factors responsible that are for the initiation, metastasis and prognosis of various types of cancer. Epidemiological research findings on cancer lead to the formulation of suitable therapeutic treatment methods and preventive medicines for cancer.

Ø Global Cancer Incidence And Mortality

Ø Descriptive Epidemiology

Session 18: Cancer Prevention And Management

Cancer prevention and management is the measures taken to lower the chance of getting cancer. In addition to the physical and emotional problems caused by cancer, the high costs of care are also a burden to patients, their families, and to the public. By preventing cancer, the number of new cases of cancer is lowered. The risk can be reduced based on the Specific type of cancer. Reducing the risk of cancer may also be through dietary and lifestyle changes. Greater than 75% of cancer deaths could be prevented by avoiding risk factors including tobacco, obesity, an insufficient diet, physical inactivity, alcohol etc..

Ø Strategies

Ø Risk Management

Market Analysis:

Cancer is a disease characterized by uncontrolled cell proliferation. There are more than 100 types of cancer. The most common causes of cancer death are cancers of Lung (1.69 million deaths),Liver (788 000 deaths),Colorectal (774 000 deaths),Stomach (754 000 deaths),Breast (571 000 deaths) account for nearly half of new cases per year.Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

The kinds of cancer we expect to increase the most are

· Melanoma (the deadliest kind of skin cancer) in white men and women.

· Prostate, kidney, liver, and bladder cancers in men.

· Lung, breast, uterine, and thyroid cancers in women.

Figure 1a,1b depicts the most common cancers expected to occur in men and women in 2018. Prostate, lung and bronchus (referred to as lung hereafter), and colorectal cancers account for 42% of all cases in men, with prostate cancer alone accounting for almost 1 in 5 new diagnoses. For women, the 3 most common cancers are breast, lung, and colorectum, which collectively represent one-half of all cases; breast cancer alone accounts for 30% all new cancer diagnoses in women.

Figure 2a,2b depict the most common causes of cancer death are cancers of the lung, prostate, and colorectum in men and the lung, breast, and colorectum in women.These 4 cancers account for 45% of all cancer deaths, with one-quarter due to lung cancer.

Importance & Scope:

Cancer science 2018 is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and provides an opportunity to meet and communicate with leading doctors,surgeons,scientists,academic professionals from around the world and listen to top speakers about the on new developments that impact and advance future of cancer science. It serves as a global platform regarding the current developments, recent advances,new approaches in the field of cancer science and therapy.This event is an effort to understand the underlying new techniques which are amended to increase effectiveness, accuracy, sustainability, and quality of life.

Pulsus Group welcomes all the Oncologists, Academicians, Industry professionals, and Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees to be a part of Cancer Science 2018. Advanced Diagnostic and therapeutic equipment along with the novel drugs for the cancer are the integrated part of cancer Diagnosis and therapy. Hence it will be an extraordinary opportunity for academicians and industry professionals as it provide new dimension which involves every aspects of recent advances in diagnostic tools and emerging technologies in cancer therapy .

Glance at cancer Market :

Worldwide cancer affects more than 10 million people each year and the incidence of cancer is expected to increase by 2.4% annually to reach 14 million per year by 2020. Cancer is the second most common death in the industrialized world.With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.

Added to the increasing cancer prevalence, there are several reasons that currently lead to an increase in the cancer therapy market. These include the availability and high development cost of better immunotherapy agents, the non-curable and serious nature of most cancers, the reduced competition among agents as the use of an agent does not preclude from the concurrent/subsequent use of another, that cheaper generics are often not considered as available alternatives to newer more costly agents but they are replaced by them, the earlier diagnoses and increased chronic management, the lack of magnitude threshold of drug benefit and increased insurance premiums due to unpredictable disease status.The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.The global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2

Why San Antonio:

San Antonio, formally known as the City of San Antonio is the second most populated city in the state of Texas and the seventh most populated city in the United States of America. San Antonio was named after Saint Anthony de Padua. The UNESCO world heritage sites in San Antonio are The Alamo and San Antonio Missions National Historic Park. The economy is based chiefly on healthcare, military, civil service, tourism, financial services & oil & gas. The city has well flourished heritage and traditions. San Fernando Cathedral, San Antonio Missions National Historical Park, Aztec Theatre, San Antonio Museum of Art, Natural Bridge Caverns, Day Trip to Bandera & New Braunfels and Sea world are outstanding places to be seen in San Antonio. San Antonio International Airport has facility from major of the International terminals. The University of Texas Health Science centre at San Antonio is the largest health sciences university and the primary training site for health professionals in South Texas. VIA Metropolitan Transit in San Antonio provide transportation all over the city.

Top universities in San Antonio:

1.The University of Texas at San Antonio

2. Trinity University

3. St. Philip’s College

4. University of the Incarnate Word

5. Texas A&M University - San Antonio

6. St. Mary’s University

7. Palo Alto College

8. San Antonio College

9. Our Lady of the Lake University

10. Wayland Baptist University

List of Associations and Societies:

1. National and International Cancer Organisations

2. American Cancer Society

3. Bahrain Cancer Society

4. Singapore Cancer Society

5. American Association for Cancer Research

6. American Society of Clinical Oncology

7. Indian Cancer Society

8. Cancer Society of Finland

9. Cancer Council South Australia

10. Esophageal Cancer Awareness Association (ECAA)

11. Childhood Cancer Initiative Kenya Cancer Association (KENCASA)

12. Kenya Hospices and Palliative Care Association (KEHPCA) /

13. Bermuda Cancer & Health Centre

14. Canadian Cancer Society

15. Turkish Association for Cancer Research and Control 

16. Moscow Cancer Relief Society

17. International Medical Association Bulgaria (IMAB) 

18. Swedish Cancer Society

19. Dutch Cancer Society

20. Norwegian Cancer Society

21. The Iceland Cancer Society

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
-----------------------------------------------------------------
This event is brought to you by:
Pulsus Group - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MAR180203CRE VIO180612UPA MYL180625UPA VIO180726UPD

Share with friends

Date and Time

Location

Venue will be informed to the Registered Participants

San Antonio, TX 78216

View Map

Refund Policy

No Refunds

Save This Event

Event Saved

Social Settings

Save This Event

Event Saved